Page 56 - ITPS-7-4

INNOSC Theranostics and
Pharmacological Sciences Biomarkers and drugs in Africa

biomarker in respiratory allergy. Int Forum Allergy Rhinol. risk of tuberculosis recurrence in HIV Co-infected patients
2019;9(12):1478-1484. from South Africa. Front Immunol. 2021;12:631094.
doi: 10.1002/alr.22426 doi: 10.3389/fimmu.2021.631094
47. Lauková L, Konečná B, Janovičová Ľ, Vlková B, Celec P. 52. Cummings J, Lee G, Mortsdorf T, Ritter A, Zhong K.
Deoxyribonucleases and their applications in biomedicine. Alzheimer’s disease drug development pipeline: 2017.
Biomolecules. 2020;10(7):1036. Alzheimers Dement (N Y). 2017;3(3):367-384.
doi: 10.3390/biom10071036 doi: 10.1016/j.trci.2017.05.002
48. Ntekim A, Olopade OI. Innovative strategies for developing 53. Jain P, Chakma B, Patra S, Goswami P. Potential biomarkers
biomarker-informed cancer clinical trials to accelerate and their applications for rapid and reliable detection of
progress in precision oncology in Sub-Saharan Africa. Am malaria. Biomed Res Int. 2014;2014:852645.
Soc Clin Oncol Educ Book. 2022;42:1-9.
doi: 10.1155/2014/852645
doi: 10.1200/EDBK_349955
54. Tribolet L, Kerr E, Cowled C, et al. MicroRNA biomarkers
49. Fathi E, Mesbah-Namin SA, Farahzadi R. Biomarkers in for infectious diseases: From basic research to biosensing.
medicine: An overview. J Adv Med Med Res. 2013;4:1701-1718. Front Microbiol. 2020;11:1197.
50. Kotta PA, Nambi V, Bozkurt B. Biomarkers for heart doi: 10.3389/fmicb.2020.01197
failure prediction and prevention. J Cardiovasc Dev Dis. 55. Seijo LM, Peled N, Ajona D, et al. Biomarkers in lung cancer
2023;10(12):488.
screening: Achievements, promises, and challenges. J Thorac
doi: 10.3390/jcdd10120488 Oncol. 2019;14(3):343-357.
51. Pillay K, Lewis L, Rambaran S, et al. Plasma biomarkers of doi: 10.1016/j.jtho.2018.11.023

Volume 7 Issue 4 (2024) 12 doi: 10.36922/itps.3656